Harry Ostrer

发表

Preconditioned Random Forest Regression: Application to Genome-Wide Study for Radiotherapy Toxicity Prediction

Joseph O. Deasy, Jung Hun Oh, Barry Rosenstein, 2017, BCB.

Harry Ostrer, Brett Baskovich, Susan Hiraki, 2016, Genetics in Medicine.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Petra Seibold, Hubert Thierens, Alison M Dunning, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Translating genomic research into clinical practice: promise and pitfalls.

Harry Ostrer, H. Ostrer, J. Sparano, 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Alterations of sex differentiation in males: from candidate genes to diagnosis and treatments.

Harry Ostrer, 2004, Current pharmaceutical design.

Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.

Jiri Zavadil, David Polsky, Harry Ostrer, 2011, Cancer research.

Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins

Kenneth Offit, Diether Lambrechts, Gil Atzmon, 2014, Nature Communications.

A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.

Richard Stock, Yongzhao Shao, Dirk De Ruysscher, 2013, International journal of radiation oncology, biology, physics.

Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.

Junjian Liu, Kenneth Offit, Virginia G Kaklamani, 2005, Cancer research.

Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry.

Itsik Pe'er, Gil Atzmon, Pier Francesco Palamara, 2010, American journal of human genetics.

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer

Richard Stock, Matthew R. Sydes, Kyriaki Michailidou, 2016, EBioMedicine.

Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.

Sarah L Kerns, Barry S Rosenstein, Harry Ostrer, 2014, Cancer discovery.

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.

Nengjun Yi, Kui Zhang, Kenneth Offit, 2011, Metabolism: clinical and experimental.

Clustering-Based Method for Developing a Genomic Copy Number Alteration Signature for Predicting the Metastatic Potential of Prostate Cancer.

Jonathan Melamed, Harry Ostrer, H. Ostrer, 2012, Journal of probability and statistics.

Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes

Joseph O. Deasy, Jung Hun Oh, Barry Rosenstein, 2017, Scientific Reports.

Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation

Yongzhao Shao, Harry Ostrer, H. Ostrer, 2013, Human Genetics.

STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics

Joseph O Deasy, Alison M Dunning, Jenny Chang-Claude, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiogenomics: radiobiology enters the era of big data and team science.

Andre Dekker, Michael Baumann, Karin Haustermans, 2014, International journal of radiation oncology, biology, physics.

Disorders of sex development (DSDs): an update.

Harry Ostrer, H. Ostrer, 2014, The Journal of clinical endocrinology and metabolism.

The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.

Nawaid Usmani, Joseph O Deasy, Jung Hun Oh, 2015, Seminars in radiation oncology.

A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci

Jennifer Mulle, Nir Giladi, Karen Marder, 2012, PLoS genetics.

The inferelator 2.0: A scalable framework for reconstruction of dynamic regulatory network models

Richard Bonneau, Eric Vanden-Eijnden, Aviv Madar, 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

Kenneth Offit, Jeffery P. Struewing, Lawrence C. Brody, 1996, Nature Genetics.

Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy.

Joseph O Deasy, Jung Hun Oh, Barry Rosenstein, 2018, International journal of radiation oncology, biology, physics.

Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma

Judith D Goldberg, Jan Zakrzewski, David Polsky, 2009, Clinical Cancer Research.

North African Jewish and non-Jewish populations form distinctive, orthogonal clusters

David Comas, Itsik Pe'er, Gil Atzmon, 2012, Proceedings of the National Academy of Sciences.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

Nawaid Usmani, Suzanne Chambers, Martin Eklund, 2018, Nature Communications.

A mutation of PCDH15 among Ashkenazi Jews with the type 1 Usher syndrome.

Karen B Avraham, Harry Ostrer, Carole Oddoux, 2003, The New England journal of medicine.

Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.

Richard Stock, Yongzhao Shao, Sarah L Kerns, 2010, International journal of radiation oncology, biology, physics.

Abnormal RNA processing due to the exon mutation of βE-globin gene

Stylianos E. Antonarakis, Stuart H. Orkin, Haig H. Kazazian, 1982, Nature.

Association of Single Nucleotide Polymorphisms in SOD2, XRCC1 and XRCC3 with Susceptibility for the Development of Adverse Effects Resulting from Radiotherapy for Prostate Cancer

Christopher A Peters, Barry S Rosenstein, Grace Fan, 2008, Radiation research.

Differential analysis of mutations in the Jewish population and their implications for diseases

Noam Shomron, Shai Carmi, Harry Ostrer, 2017, Genetics research.

How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?

Ying Xiao, Jacek Capala, Jeff Hammerbacher, 2016, International journal of radiation oncology, biology, physics.